Pharmaco-metabolomics

Pharmacometabolomics/Pharmacometabonomics is used to determibe the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmacometabolomics is still in its infancy because most pharmacometabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors such as diets, ages, drug intake and gut microbiota with drug responses or disease susceptibility to study and minimize the metabolic biases.

 

    Related Conference of Pharmaco-metabolomics

    April 16-17, 2020

    16th World Congress on Structural Biology

    Amsterdam, Netherlands
    April 20-21, 2020

    11th Tissue Science and Regeneration Congress

    Kualalumpur, Malaysia
    June 28-30 2020

    globalbiotechnology-cs-2020

    June 28-30 2020

    oilgas-cs-2020

    June 28-30 2020

    BEHAVIOURAL SCIENCE-2020

    June 28-30 2020

    Bioinfo 2020

    May 10-11, 2020

    26th World Nursing & Nurse Practitioner Conference

    Yokohama, Japan
    July 17-18, 2020

    10th Glycobiology World Congress

    Vienna, Austria
    August 4-5, 2020

    12th Euro Biosensors & Bioelectronics Congress

    Zurich, Switzerland
    September 28-29, 2020

    2nd International Conference on Metabolomics, Genomics and Proteomics

    Singapore City, Singapore
    September 28-29, 2020

    19th International Conference on Structural Biology

    Barcelona, Spain
    October 08-09, 2020

    10th European Biosimilars Summit

    Milan, Italy
    October 14-15, 2020

    9th World Congress on Glycobiology & Glycochemistry

    Rome, Italy

    Pharmaco-metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in